# From Scandal to Infrastructure ## Scope and method This report does two things at once. It **audits the project material that was actually available in this session**, and it **rebuilds the stronger, better-sourced argument from the open web**: that the most defensible way to reframe the Epstein/Trump tangle is not through **denial**, **exoneration**, or **moral panics**, but through a distinction between **scandal as an attention sink** and **reproductive-selection infrastructure as the deeper institutional story**. The phrase **epistemic heat sink** is an analytical inference here: it means a scandal field absorbing public attention so completely that adjacent systems, technologies, markets, and policies become harder to see. That inference is supported by the fact that public coverage around Epstein overwhelmingly centered crime and sensational harm, while, in parallel, fertility policy, embryo screening, and consumer genomics continued to formalize and commercialize selection in fully visible institutional channels. citeturn3news0turn3news1turn5view1turn25view0turn29view0 A methodological limit matters up front. In this session, no queryable project archive beyond the conversation-embedded project summary was available through file retrieval, so the “archive audit” below is necessarily limited to the **single project-summary document provided in context**, rather than a full multi-file repository crawl. Where the archive summary includes claims that I could not confirm from a high-confidence source in this run, I mark them as **partial**, **weak**, or **needs primary evidence** rather than inflating certainty. ## Project-material audit Because only one accessible project-summary document was available here, the audit is organized around the main clusters inside that document rather than a multi-file filename inventory. The core editorial move in the project materials is clear and, in my view, substantively correct: **strip away underage material, speculative coordination claims, probability theater, and partisan “exoneration” rhetoric; retain the visible, aboveboard infrastructure of reproductive technology and selection.** | Filename or accessible project item | Summary of what it contributes | Status after open-web check | Missing or weak evidence | |---|---|---|---| | `Pasted text.txt` or conversation-embedded project summary | Establishes a hard exclusion boundary around teen-pageant material, speculative Trump–Epstein coordination, probability percentages, and “Trump exoneration” framing; retains Church/Digid8, PES, IVG, Venter/HLI, Lanza, Epstein’s reproductive ambitions, Pinker, commercialization timeline, and LIMIT statements | **Strong as editorial architecture**; **mixed as evidentiary package** | The architecture is stronger than some individual evidentiary links. Several retained items still need tighter sourcing before publication. | | Church / Digid8 cluster | Church accepted Epstein-linked funding in 2005–2007; later met Epstein post-conviction; Digid8 announced in late 2019 as a genetics-based pairing or compatibility concept | **Partial** | Church’s funding relationship is well attested in later summaries and institutional reporting, but **Digid8-specific details were not recoverable from primary sources in this run**. I would not make Digid8 a load-bearing claim without a directly retrievable CBS/MIT Technology Review source. citeturn20search0turn20search2 | | PES cluster | Commercial embryo-selection services moved from speculative debate into clinical and quasi-clinical use; the first baby selected through polygenic embryo screening was publicly reported in 2021 and discussed in a 2022 Columbia bioethics article | **Strong** | The “first PES baby” claim is sourceable; however, any stronger clinical-efficacy claim should stay tightly qualified because even the bioethics literature stresses uncertainty, thin guidelines, and high controversy. citeturn29view0 | | IVG cluster | In vitro gametogenesis is the horizon technology that could expand embryo supply and therefore broaden selection possibilities | **Partial but directionally strong** | The general implication is correct, but some specific review papers named in the project summary were not cleanly retrievable here. Keep IVG claims at the level of **developmental trajectory and technical implication**, not near-term clinical certainty. citeturn30news6turn30news8 | | Venter / Human Longevity cluster | Human Longevity represents the longevity-genomics side of the same infrastructural turn, but without a documented direct Epstein funding link | **Strong** | No direct Epstein financing connection surfaced in this run, so the project’s own LIMIT statement is exactly the right discipline. citeturn21search1turn21news7 | | Lanza cloning / telomere cluster | Positions cloning and longevity research as part of the wider optimization-and-continuity frame | **Weak in this run** | I did not recover the specific Lanza source chain cleanly enough to make it central. This can be omitted without hurting the article. | | Epstein reproductive-ambition cluster | Reframes Epstein not only as a criminal scandal figure but as someone who explicitly voiced reproductive/transhumanist ambitions, including the “seed the human race with his DNA” plan | **Strong** | The sourcing is media-based rather than self-authored primary documentation, but the reporting itself is well established. Keep the claim strictly at the level of **reported ambition**, not implemented program. citeturn10news0 | | Pinker cluster | Suggests Pinker publicly defended embryo selection or minimized “enhancement” panic | **Weak / needs direct source** | I did not recover the claimed August 2025 post directly. Do not make this point central without the original post or an authoritative transcript. | | Trump assisted-reproduction cluster | Argues that Trump’s clearest, cleanest distinction from the Epstein-adjacent narrative lies in his **public, law-facing support for reproductive technology** | **Very strong** | This is the best-documented spine in the whole package and should carry the article’s Trump-specific section. citeturn5view0turn3news0turn3news1turn5view1turn5view2 | The upshot is simple. The project’s **editorial pruning is sound**, but the strongest publishable structure should rely primarily on **Trump’s documented IVF policy record**, **commercialization of embryo and fertility genomics**, **the publicly visible march of fertility-benefit regulation**, and **qualified discussion of selection as a permanent feature of human reproductive systems**. Claims about **Digid8**, **Pinker**, and some of the more elaborate Church framing should be treated as supplementary unless upgraded with primary documentation. citeturn5view0turn5view1turn5view2turn25view0turn29view0 ## Trump’s public reproductive-technology record If the goal is to distinguish **lawful, transparent participation in reproductive technology** from lurid narratives about hidden sexual predation, Trump’s assisted-reproduction record is the strongest evidentiary anchor available. Executive Order **14216**, signed on **February 18, 2025**, states that it is administration policy to ensure reliable access to IVF and directs the Domestic Policy apparatus to produce recommendations within 90 days on protecting IVF access and reducing both out-of-pocket and health-plan costs. The text also explicitly frames family formation as a public-policy objective rather than a private luxury. citeturn5view0 Reuters and AP both reported at the time that the order did **not itself create a funding mechanism or mandate universal coverage**, but it did formalize IVF access as a White House priority. Reuters additionally noted the administration’s emphasis on lowering regulatory burdens and on the scale of IVF births already occurring in the United States. citeturn9news5turn8news3 By **May 2025**, the White House was still reviewing the recommendations required by that order, which is important because it shows a real policy process rather than just campaign rhetoric. At the same time, it also demonstrates that the February order was a framework document, not a finished benefits regime. citeturn3news2 By **August 2025**, however, the administration had still **not** moved to implement the more sweeping campaign pledge that either government or insurers would simply pay for IVF. The Washington Post reported that the White House did not plan to require insurers to cover IVF, despite Trump’s 2024 campaign statement that the government would pay for it or insurers would be mandated to do so. That gap is not a minor footnote; it is part of the honest record and should stay in the article. citeturn9news2 The most concrete policy movement came on **October 16, 2025**. Reuters, AP, Politico, Time, and The Washington Post all reported a Trump administration package built around two levers: cheaper fertility drugs and a pathway for employers to offer standalone fertility benefits. Reuters reported that EMD Serono agreed to offer **Gonal-f, Ovidrel, and Cetrotide** through a direct-to-consumer route, with an **84% discount off list prices when all three are used in a typical IVF protocol**, and that the drugs would also participate in the **TrumpRx.gov** direct purchasing platform. EMD Serono’s own press release confirms the same drug list, the same **84% discount** claim, and the company’s participation in TrumpRx.gov, which it said would go live in **January 2026**. citeturn3news1turn5view2turn6view2turn6view3turn6view4 At the regulatory level, the most consequential text is the **Federal Register** proposal on **Excepted Fertility Benefits**, published on **May 13, 2026**. The proposed rule would create a new category of **limited excepted benefits** for fertility coverage, which would let employers and issuers offer separate fertility benefits outside the standard major-medical bundle if certain conditions are met. The proposal repeatedly identifies a **$120,000 lifetime dollar limit**, indexed for medical inflation in later plan years, as the ceiling for such benefits. In other words, the administration moved from general IVF rhetoric toward a recognizable insurance design architecture: not universal IVF as an essential health benefit, but a distinct employer-coverage pathway analogous in structure to dental or vision-style benefit separations. citeturn5view1turn6view0turn6view1 Trump also personally yoked himself to fertility politics rhetorically. In March 2025, he referred to himself as the **“fertilization president”** at a White House event, after having already called himself the **“father of IVF”** on the campaign trail. That rhetoric is not policy, but it matters culturally: it casts reproductive technology as a public badge of political identity rather than a private embarrassment. citeturn8news1turn9news0 The policy timeline is therefore concrete enough to summarize in full: | Date | Action | What is firmly documented | Sources | |---|---|---|---| | February 18, 2025 | Executive Order 14216 signed at Mar-a-Lago | Orders policy recommendations on protecting IVF access and reducing out-of-pocket and plan costs; declares IVF access a policy priority | citeturn5view0turn9news5turn8news3 | | May 2025 | White House review stage | Domestic Policy Council had completed recommendations, but no final plan was public | citeturn3news2 | | August 2025 | Coverage-mandate gap becomes explicit | White House had no plan to require insurers to cover IVF despite the campaign pledge | citeturn9news2 | | October 16, 2025 | Fertility-drug affordability push | EMD Serono deal for Gonal-f, Ovidrel, and Cetrotide; up to 84% off list prices in a typical protocol; TrumpRx.gov participation | citeturn3news1turn5view2turn6view2turn6view3turn6view4 | | May 13, 2026 | Proposed fertility-benefit rule | New category of excepted fertility benefits with a proposed $120,000 lifetime cap and separate employer-offering pathway | citeturn5view1turn6view0turn6view1 | The crucial interpretive point is that this places Trump, whatever else one thinks of him, **inside the visible governance of reproductive technology**. The record is therefore not one of secret reproductive plotting but of **public IVF advocacy, regulatory repositioning, cost politics, and pronatal policy branding**. That does **not** erase any other controversy in his life; it simply identifies the strongest available evidence for the argument the project wants to make. citeturn5view0turn3news1turn5view1 ## Selection infrastructure beyond scandal The broader infrastructure story is even stronger than the Trump-specific policy story, because it shows that **selection did not disappear after eugenics became morally radioactive**; it migrated into **clinical genomics**, **consumer fertility markets**, **insurance design**, and **bioethical dispute**. That is the argument’s center of gravity. The clearest documentary milestone in that transition is **polygenic embryo screening**. A 2022 article in **Voices in Bioethics** at Columbia states that in **September 2021** Bloomberg reported the birth of **“the first baby born after polygenic embryo screening,”** a child called **Aurea**, whose parents had used IVF and polygenic screening to choose among **33 embryos** in **2020**. The same article also emphasizes that the public reaction turned on exactly the issues your project is trying to clarify: uncertainty of predictive accuracy, lack of professional guidance, and fear of a eugenic future once embryo choice moves beyond single-gene disease avoidance into statistical risk scoring and trait discussion. citeturn29view0 What matters conceptually is not whether one approves of PES. What matters is that **the selection function has already become clinical and commercial**. Columbia’s article describes a field in which companies were already marketing embryo selection for common conditions and, in some discourse, for non-medical traits. That alone is enough to refute any naïve assumption that selection vanished from modernity because the old vocabulary became taboo. citeturn29view0 The commercialization frontier is even clearer in **Nucleus**. Nucleus’s own site advertises embryo and IVF services under the slogan **“Have your best baby.”** It says per-parent screening covers **2,000+ hereditary diseases**, that its IVF+ package includes **embryo analysis for up to 20 embryos**, and that it offers **genetic optimization software for 30+ diseases and traits**. The site also lists a starting price of **$9,999 per month for four months**, which implies a program cost at or around **$40,000** before clinic-specific variation. It further claims that the service is trusted by **165+ clinics around the world**. This is not fringe internet fantasy; it is an explicit market interface for parental selection. citeturn25view0turn26view2turn26view4 The longevity-genomics branch of the same ecosystem is represented by **Human Longevity, Inc.** Craig Venter announced the company with co-founders in **March 2014**, with an ambition to use large-scale genomics and machine learning to extend healthy lifespan. Reuters reported the launch at the time, and later summaries note the company’s planned sequencing scale and the broader orientation toward genotype–phenotype aggregation. What is important for your argument is not any alleged secret connection to Epstein, because I did **not** find one. What matters is that Venter’s work demonstrates the **normalization of human optimization narratives** through genomics, diagnostics, and longevity entrepreneurship. citeturn21search1turn21news7turn21news5 The most speculative but still important frontier is **in vitro gametogenesis**. Reuters reported in early 2025 on new work producing mice with two male parents via stem-cell and imprinting interventions, while later reporting on IVG research described active progress toward lab-grown eggs and sperm and the possibility—still not a clinic-ready reality—of making reproduction less constrained by existing gamete supply. The key inference, which should be labeled as an inference, is that if IVG matures, **embryo supply increases**, and if embryo supply increases, **selection expands**, because choice operates over a larger candidate pool. citeturn30news8turn30news6 Epstein enters this picture not as a necessary causal architect of the fertility market, but as a figure whose reported ambitions rhyme disturbingly with the infrastructure that later matured around him. Reporting summarized by **Vanity Fair**, based on a 2019 **New York Times** story, said Epstein wanted to **impregnate multiple women at his New Mexico ranch** and to **“seed” the human race with his DNA**, while also pursuing a bizarre cryonics fantasy involving the preservation of his head and penis. Whether delusional, narcissistic, or technically incoherent, those ambitions belong to the semantic field of **reproductive futurity**, **lineage**, **self-extension**, and **transhumanist fantasy**, not merely to ordinary vice. That is analytically relevant even if one refuses all stronger coordination claims. citeturn10news0 The timeline below captures the stronger, higher-confidence infrastructure arc: ```mermaid timeline title Selection and reproductive-technology infrastructure 2014 : Human Longevity launched by Craig Venter and co-founders 2020 : Embryo chosen in the later-reported first PES birth 2021 : Bloomberg reports first baby born after polygenic embryo screening 2022 : Columbia bioethics article synthesizes expert concern over PES 2025 : EO 14216 makes IVF access a White House policy priority 2025 : Trump-EMD Serono pricing package announced 2026 : Proposed Federal Register rule creates excepted fertility benefits pathway ``` The important conclusion is not that all these nodes belong to one hidden conspiracy. That would be weakly supported. The conclusion is narrower and stronger: **selection has been migrating from informal culture and personal preference into explicit biomedical, actuarial, and consumer interfaces.** The scandal did not create that infrastructure, and the infrastructure does not depend on scandal to exist. citeturn21search1turn29view0turn5view0turn3news1turn5view1 ## Adult institutions of appraisal To make the selection thesis intelligible to a common reader, it helps to say plainly that **pageants, dating systems, fertility screening, and high-status mate markets are not identical things, but they all formalize appraisal**. They are social technologies for ranking, signaling, and filtering. Evolutionary theory has long treated sexual display as a signaling problem. Zahavi’s **handicap principle** is one canonical model: costly signals can function as honest signals because they are difficult to fake. That does not prove anything specific about pageants, but it does give the deepest natural-history backdrop for why visible display and public comparison are never culturally arbitrary. citeturn33search3turn33search9 Modern pageants then turn some of that diffuse display logic into an institution. **Miss Universe** remains, in the plainest terms, an international beauty pageant; its format historically included categories such as **swimwear** and **evening gown**, while its eligibility rules have themselves become a public battleground over what sorts of women count as eligible for prestige display. The organization’s own history, as captured in widely cited coverage and summaries, places **Donald Trump’s ownership from 1996 to 2015** directly inside that adult appraisal apparatus. citeturn31search6turn34search2 This is exactly why pageants are analytically useful. They show that societies do not merely experience attraction privately; they also **codify aesthetic judgment**, **ritualize comparison**, and **institutionalize standards**, even when those standards later soften or diversify. The 2018 removal of the swimsuit competition from **Miss America**, for example, was widely framed as a move away from judging “outward physical appearance.” But that reform did not abolish appraisal; it changed the weighting and declared a new legitimacy rule for what kinds of evaluation were publicly acceptable. In other words, the institution did not cease to be a selection-and-status machine. It changed its officially sanctified inputs. citeturn33news8turn33search11 Miss Universe’s own recent history makes the same point from another angle. The organization removed the upper age limit and broadened eligibility to married women and mothers while retaining the pageant as a prestige competition among adult women. That is not the end of selection. It is **reparameterization** of selection. The standards change; the sorting function survives. citeturn35search5turn35search1 That is the bridge your article needs: not “pageants are eugenics,” which is sloppy and historically explosive, but **pageants are one adult cultural technology among many that make trait appraisal public, stylized, and competitive**. Once readers grant that point, it becomes much easier to explain why fertility genomics, embryo scoring, and genetic optimization are not alien intrusions from nowhere. They are new interfaces laid over an old human preoccupation. citeturn33search3turn33news8turn29view0turn25view0 ## Article draft ### Executive summary The strongest defensible version of this article is not a brief for anyone’s innocence. It is an argument about **attention structure**. The Epstein scandal became so morally overwhelming that it trained the public to read every adjacent fact as merely another clue in a sex-crime melodrama. That public habit obscured a parallel and more durable reality: **human societies never stopped building selection systems**, and in the last decade those systems have moved with increasing clarity into **IVF policy, embryo scoring, consumer genomics, fertility insurance design, and longevity science**. Trump’s public reproductive-policy record belongs in that visible world of state-facing reproductive technology. Epstein’s reported reproductive fantasies belong in a darker, more pathological but still recognizably reproductive and transhumanist imaginary. The explanatory mistake is to let the scandal exhaust the ontology. citeturn5view0turn3news1turn5view1turn29view0turn10news0 ### Draft text The public story about Jeffrey Epstein and Donald Trump has been told in a vocabulary so saturated with disgust that it has become difficult to see anything else. The words come first and everything else follows behind them: **pedophile**, **predator**, **island**, **blackmail**, **elite depravity**, **cabal**. Once those symbols take over, the public mind stops differentiating between very different kinds of evidence. A fertility policy becomes suspect by adjacency. A genetics discussion becomes sinister by association. A reproductive ambition becomes indistinguishable from a sex crime in the popular imagination. That is not analysis. It is a kind of cognitive collapse. citeturn3news0turn10news0 The more rigorous interpretation begins by refusing to let scandal do all the explanatory work. This is not because scandal is unreal. It is because scandal can become an **epistemic heat sink**: a morally incandescent event that absorbs so much public attention that surrounding institutions become illegible. Around Epstein, public attention fixed almost entirely on criminality and taboo. Meanwhile, outside the scandal frame, a different historical process kept advancing in plain sight: **the technologization of selection** through reproductive medicine, genomics, and policy. citeturn5view0turn5view1turn29view0turn25view0 That deeper process is older than any one man. Human beings have always built systems for evaluating mating value, lineage, beauty, health, prestige, and future prospects. Sometimes those systems are informal, as in courtship and mate choice. Sometimes they are ceremonial, as in pageants. Sometimes they are commercial, as in donor markets and fertility clinics. Sometimes they are medical, as in IVF and embryo screening. The crucial point is that **selection never vanished** simply because the twentieth century discredited coercive eugenics. What vanished, or was driven underground, was the old rhetoric of state-directed biological hierarchy. The selection function itself persisted and changed media. citeturn33search3turn33news8turn29view0 Beauty pageants are instructive here because they make public what most societies otherwise do semi-consciously. They stage appraisal. They create prestige through comparison. They attach legitimacy to standards, then periodically renegotiate those standards as culture shifts. Miss America’s elimination of the swimsuit competition in 2018 did not abolish appraisal; it redistributed which dimensions of appraisal could be openly honored. Miss Universe’s later widening of age and family-status eligibility did not end competitive display; it altered the permitted population while preserving the ranking mechanism. These institutions matter not because they are identical to biotechnology, but because they reveal how deeply societies normalize public trait evaluation long before genes enter the conversation. citeturn33news8turn35search5 Once that is clear, modern reproductive technology looks less like an alien ethical rupture and more like a new layer of explicitness. A 2022 Columbia bioethics article documented the public controversy after the first baby born following polygenic embryo screening was reported in 2021. The article emphasized both the extraordinary significance of the milestone and the unease surrounding it: thin professional guidance, uncertain predictive validity, fears of discrimination, and the possibility that embryo choice would move from disease avoidance toward a broader menu of health and trait optimization. In other words, the public was not reacting to a hypothetical future. It was reacting to the fact that the infrastructure had already begun to arrive. citeturn29view0 That arrival is now commercial as well as clinical. Nucleus openly markets preconception and embryo services under the slogan **“Have your best baby,”** offering parent screening for **2,000+ hereditary diseases**, embryo analysis for **up to 20 embryos**, and “genetic optimization” across multiple diseases and traits. One need not embrace the company’s rhetoric to see what it represents: selection translated into a user interface, a checkout flow, a counseling package, and a clinic network. The moral taboo did not stop the market. It only changed the vocabulary through which the market speaks. citeturn25view0turn26view2turn26view4 The state has moved in the same direction. Trump’s reproductive-technology record is therefore not a trivial side note; it is part of the infrastructure story. Executive Order 14216 made IVF access a formal presidential concern in February 2025. The October 2025 package with EMD Serono tied reproductive policy to drug pricing, while the 2026 Federal Register proposal on excepted fertility benefits began building a new employer pathway for standalone fertility coverage. One can fairly criticize the administration for not fulfilling the broader campaign promise of mandated coverage. But one cannot honestly deny that the administration placed itself squarely inside the governance of assisted reproduction. That is not clandestine reproductive intent. It is public reproductive policy. citeturn5view0turn9news2turn3news1turn5view1 Epstein belongs in this story differently. The strongest public reporting does not show that he built the fertility market, nor that he orchestrated its subsequent commercialization. It does show that he reportedly spoke in the language of reproductive futurity and self-extension: the desire to impregnate multiple women at a ranch, to “seed” the human race with his DNA, and to imagine cryonic persistence after death. These fantasies are not ordinary. But they are also not conceptually random. They belong to the same historical weather system in which genomics, longevity, enhancement, and human continuity increasingly became elite obsessions. The scandal narrative made it easy to treat all of this as mere depravity with props. The more disciplined view is that depravity and futurist biological ambition can coexist, and that reducing everything to the first term blinds us to the second. citeturn10news0 This is why the scandal frame is too small. It does not fail because crime is irrelevant. It fails because crime is not the whole ontology. The real historical movement is the migration of selection from diffuse culture into explicit infrastructures: pageants into prestige systems, IVF into public policy, embryo scoring into clinical products, fertility coverage into insurance design, genomics into consumer dashboards, longevity into venture capital, and reproductive judgment into software. The public keeps staring at the heat sink. The machinery keeps advancing behind it. citeturn33news8turn29view0turn25view0turn21search1turn5view1 The right conclusion is not complacency. It is adulthood. Societies are not choosing between selection and no selection. They are choosing between **transparent, plural, argued-over selection systems** and **selection systems that remain subterranean, disavowed, and therefore harder to govern**. The word “eugenics” still carries so much historical toxin that many people can no longer think their way through the difference between coercive state biopolitics and the heterogeneous, privatized, consumerized, and medicalized selection systems that increasingly structure modern reproduction. But history does not pause for conceptual embarrassment. The infrastructure is already here. citeturn29view0turn25view0turn5view1 ## Open questions and source appendix Several parts of the project remain worth pursuing, but they are not yet strong enough to bear major argumentative weight in a rigorous published article. The main unresolved items are **Digid8-specific primary documentation**, the exact **George Church post-conviction meetings** record in primary institutional documents rather than later summaries, the claimed **Steven Pinker August 2025 post**, and the more weakly sourced **Lanza/telomere** strand. The article does not need those points to work. In fact, it becomes stronger if it rests on the more visible and legally legible infrastructures already summarized above. citeturn20search0turn20search2 A second limit is analytical rather than evidentiary. The phrase **epistemic heat sink** is an interpretation, not a quotation from any source. What supports it is the documented coexistence of two different public realities: overwhelming scandal attention on the one hand, and steady movement in reproductive-policy, fertility-market, and embryo-selection systems on the other. That inference is, in my judgment, robust. But it should still be presented as an inference. citeturn3news0turn3news1turn5view1turn25view0turn29view0 ### Sourced URLs ```text https://www.federalregister.gov/documents/2025/02/24/2025-03064/expanding-access-to-in-vitro-fertilization https://apnews.com/article/143316eda581ac466cd923cdf4568d87 https://www.reuters.com/business/healthcare-pharmaceuticals/trump-signs-executive-order-expanding-access-ivf-white-house-says-2025-02-18/ https://apnews.com/article/1e7a626e88d7d7a120b0c4a7ba6f8314 https://www.washingtonpost.com/business/2025/08/03/trump-administration-ivf-care/ https://www.reuters.com/business/healthcare-pharmaceuticals/white-house-set-announce-proposal-seeking-make-ivf-more-accessible-nyt-reports-2025-10-16/ https://apnews.com/article/2c168dcc0ec7250db16b0a671aea9db8 https://www.emdserono.com/us-en/company/news/press-releases/agreement-with-u-s-government-to-expand-access-to-ivf-therapies-16-10-2025.html https://www.federalregister.gov/documents/2026/05/13/2026-09479/excepted-fertility-benefits https://people.com/donald-trump-nicknames-himself-fertilization-president-womens-history-month-11704347 https://journals.library.columbia.edu/index.php/bioethics/article/view/9467 https://mynucleus.com/ https://mynucleus.com/embryo https://mynucleus.com/ivf https://www.reuters.com/science/scientists-use-genetic-engineering-create-mice-with-two-male-parents-2025-01-28/ https://www.theguardian.com/science/2025/jul/05/lab-grown-sperm-and-eggs-scientists-reproduction https://www.reuters.com/business/healthcare-pharmaceuticals/for-his-next-act-genome-wiz-craig-venter-takes-aging-2014-03-04/ https://apnews.com/article/5cb52ba1598044c1767b58a21f519810 https://www.vanityfair.com/news/2019/07/jeffrey-epstein-transhumanism-cryonics https://time.com/5303443/miss-america-swimsuit-competition-history/ https://time.com/4031437/donald-trump-miss-universe-pageant/ ```